European Registry of Cardiac Arrest - Study-THREE (EuReCa THREE) - An international, prospective, multi-centre, three-month survey of epidemiology, treatment and outcome of patients with out-of-hospital cardiac arrest in Europe - The study protocol.
Epidemiology
EuReCa
Out-of-hospital cardiac arrest
Survival
Journal
Resuscitation plus
ISSN: 2666-5204
Titre abrégé: Resusc Plus
Pays: Netherlands
ID NLM: 101774410
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
06
09
2022
revised:
20
09
2022
accepted:
21
09
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
15
10
2022
Statut:
epublish
Résumé
The aim of the European Registry of Cardiac Arrest (EuReCa) network is to provide high quality evidence on epidemiology of out-of-hospital cardiac arrest (OHCA) in Europe by supporting and developing cardiac arrest registries and performing European-wide studies. To date, the EuReCa ONE and EuReCa TWO studies have involved around 28 countries, with population covered increasing from the first to the second study. The aim of the EuReCa THREE study is to build on previous work and to support the promotion of quality data collection on OHCA throughout Europe. EuReCa THREE will be the third prospective cohort study on epidemiology of OHCA and will involve around 30 European countries. The study will be conducted between 1st September and 30th November 2022. Data will be collected on cardiac arrest cases attended, resuscitation attempted, patient and cardiac arrest event characteristics and outcomes (including return of spontaneous circulation, status on hospital arrival and discharge). A particular focus for EuReCa THREE will be to describe key time intervals in OHCA management; time from call to EMS arrival on scene, time from cardiac arrest to start CPR, time from EMS arrival to delivery of patient to hospital.EuReCa THREE was registered with the German Registry of Clinical Trials Registration Number: DRKS00028591 searchable via WHO meta-registry (https://apps.who.int/trialsearch/). The EuReCa THREE study will increase our knowledge on longitudinal OHCA epidemiology and provide new knowledge on crucial time intervals in OHCA management in Europe. However, the primary aim of building a network to support quality data on OHCA, remains the central tenant of the EuReCa project.
Sections du résumé
Background
UNASSIGNED
The aim of the European Registry of Cardiac Arrest (EuReCa) network is to provide high quality evidence on epidemiology of out-of-hospital cardiac arrest (OHCA) in Europe by supporting and developing cardiac arrest registries and performing European-wide studies. To date, the EuReCa ONE and EuReCa TWO studies have involved around 28 countries, with population covered increasing from the first to the second study. The aim of the EuReCa THREE study is to build on previous work and to support the promotion of quality data collection on OHCA throughout Europe.
Methods/design
UNASSIGNED
EuReCa THREE will be the third prospective cohort study on epidemiology of OHCA and will involve around 30 European countries. The study will be conducted between 1st September and 30th November 2022. Data will be collected on cardiac arrest cases attended, resuscitation attempted, patient and cardiac arrest event characteristics and outcomes (including return of spontaneous circulation, status on hospital arrival and discharge). A particular focus for EuReCa THREE will be to describe key time intervals in OHCA management; time from call to EMS arrival on scene, time from cardiac arrest to start CPR, time from EMS arrival to delivery of patient to hospital.EuReCa THREE was registered with the German Registry of Clinical Trials Registration Number: DRKS00028591 searchable via WHO meta-registry (https://apps.who.int/trialsearch/).
Discussion
UNASSIGNED
The EuReCa THREE study will increase our knowledge on longitudinal OHCA epidemiology and provide new knowledge on crucial time intervals in OHCA management in Europe. However, the primary aim of building a network to support quality data on OHCA, remains the central tenant of the EuReCa project.
Identifiants
pubmed: 36238583
doi: 10.1016/j.resplu.2022.100314
pii: S2666-5204(22)00114-X
pmc: PMC9551137
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100314Informations de copyright
© 2022 The Author(s).
Références
Resuscitation. 2021 Sep;166:101-109
pubmed: 34146622
BMJ Open. 2020 Jul 8;10(7):e038133
pubmed: 32641339
Resuscitation. 2020 Dec;157:230-240
pubmed: 33049385
N Engl J Med. 2020 Jul 30;383(5):496-498
pubmed: 32348640
Resuscitation. 2011 Aug;82(8):965-6
pubmed: 21684059
Resuscitation. 2021 Apr;161:61-79
pubmed: 33773833
Resuscitation. 2020 Mar 1;148:218-226
pubmed: 32027980
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Stroke. 2020 Jul;51(7):1991-1995
pubmed: 32438895
Resuscitation. 2019 Mar;136:78-84
pubmed: 30572073
N Engl J Med. 2020 Jul 23;383(4):400-401
pubmed: 32383831
Resuscitation. 2011 Aug;82(8):989-94
pubmed: 21507548
Lancet Public Health. 2020 Aug;5(8):e437-e443
pubmed: 32473113
Curr Opin Crit Care. 2015 Jun;21(3):215-9
pubmed: 25887301
Resuscitation. 2015 Nov;96:328-40
pubmed: 25438254
Resuscitation. 2016 Aug;105:188-95
pubmed: 27321577
N Engl J Med. 2020 Aug 13;383(7):691-693
pubmed: 32427432